Ligand validation:5LFV

MAN: alpha-D-mannopyranose

MAN is a Ligand Of Interest in 5LFV designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5LFV_MAN_A_401	47%	44%	0.167	0.907	0.97	1.23	1	2	0	0	100%	0.9167
5LFV_MAN_B_401	45%	44%	0.183	0.914	1.05	1.16	1	2	0	0	100%	0.9167
5LFR_MAN_B_401	45%	42%	0.187	0.921	0.95	1.35	1	2	0	0	100%	0.9167
1GAI_MAN_A_480	100%	74%	0.043	0.986	0.45	0.53	-	-	0	0	100%	0.9167
5M03_MAN_A_402	99%	59%	0.034	0.989	0.56	0.99	-	-	0	0	92%	0.9167
1GAH_MAN_A_479	99%	76%	0.05	0.989	0.44	0.5	-	-	0	0	100%	0.9167
1BXO_MAN_A_328	99%	39%	0.05	0.985	1.37	1.08	1	1	0	0	100%	0.9167
7LTB_MAN_B_101	99%	58%	0.053	0.985	0.73	0.85	-	1	0	0	100%	0.9167

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.